LB Pharmaceuticals Inc.
LBRX Nasdaq
SEC CIK 1691082
Follow LB Pharmaceuticals
Weekly email: filings, results
Net income
−$59.1M
−1561% vs same quarter last year
EPS, diluted
−$1.79
−193.4% vs same quarter last year
Operating cash flow
−$64.3M
−1806.1% vs same quarter last year
Source: SEC XBRL filings · latest filing